What are the main challenges surrounding primary prevention trials for Alzheimer’s? Should researchers be exploring alternative avenues to amyloid-β in these trials? Take a look at our interview with Randall Bateman to find out more.
For World Brain Tumor Day (8 June), Gene Barnett, a neurosurgeon at the Cleveland Clinic (OH, USA) discusses common perceptions around brain tumors and their work with ‘tumor-treating fields’.
In one of the largest studies of its kind, researchers have revealed that long-term use of some anticholinergics could be associated with an increased risk of dementia.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.
With rates of Alzheimer’s disease predicted to continue rising, researchers have directed their focus toward individualized prevention.
New research from the University of Edinburgh highlights how an olive oil component, oleic acid, inhibits cancer-causing proteins in the brain.
Barts Charity will fund three projects looking to find ways of preventing neurodegenerative disease, with particular focus on simple treatments.
We spoke to Steven DeKosky about his contributions to neurology, his thoughts on future directions for Alzheimer’s and TBI research, and what it was like to see himself portrayed on the big screen.
Researchers demonstrate that the drug laquinimod may reduce prevalence of multiple sclerosis and slow progression of the disease in animal models.
A 9-year study reveals four new inflammatory biomarkers that have the potential to be prognostic of stroke development when present in high levels in the blood.